-
1
-
-
34248138496
-
-
Szallasi, A.; Cortright, D. N.; Blum, C. A.; Eid, S. R. Nat. Rev. Drug Discovery 2007, 6, 357
-
(2007)
Nat. Rev. Drug Discovery
, vol.6
, pp. 357
-
-
Szallasi, A.1
Cortright, D.N.2
Blum, C.A.3
Eid, S.R.4
-
3
-
-
67349241526
-
-
Kym, P. R.; Kort, M. E.; Hutchins, C. W. Biochem. Pharmacol. 2009, 78, 211
-
(2009)
Biochem. Pharmacol.
, vol.78
, pp. 211
-
-
Kym, P.R.1
Kort, M.E.2
Hutchins, C.W.3
-
4
-
-
79952821397
-
-
U.S. Patent 20090156599, CAN 151:56868.
-
Branstetter, B. J.; Breitenbucher, J. G.; Lebsack, A. D.; Liu, J.; Rech, J. C.; Xiao, W. U.S. Patent 20090156599, 2009, CAN 151:56868.
-
(2009)
-
-
Branstetter, B.J.1
Breitenbucher, J.G.2
Lebsack, A.D.3
Liu, J.4
Rech, J.C.5
Xiao, W.6
-
5
-
-
72049097706
-
-
Luke, R. W. A.; Ballard, P.; Buttar, D.; Campbell, L.; Curwen, J.; Emery, S. C.; Griffen, A. M.; Hassall, L.; Hayter, B. R.; Jones, C. D.; McCoull, W.; Mellor, M.; Swain, M. L.; Tucker, J. A. Bioorg. Med. Chem. Lett. 2009, 19, 6670
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 6670
-
-
Luke, R.W.A.1
Ballard, P.2
Buttar, D.3
Campbell, L.4
Curwen, J.5
Emery, S.C.6
Griffen, A.M.7
Hassall, L.8
Hayter, B.R.9
Jones, C.D.10
McCoull, W.11
Mellor, M.12
Swain, M.L.13
Tucker, J.A.14
-
6
-
-
0034679850
-
-
Baettig, U.; Brown, L.; Brundish, D.; Dell, C.; Furzer, A.; Garman, S.; Janus, D.; Kane, P. D.; Smith, G.; Walker, C. V.; Cockcroft, X.; Ambler, J.; Mitchelson, A.; Talbot, M. D.; Tweed, M.; Wills, N. Bioorg. Med. Chem. Lett. 2000, 10, 1563
-
(2000)
Bioorg. Med. Chem. Lett.
, vol.10
, pp. 1563
-
-
Baettig, U.1
Brown, L.2
Brundish, D.3
Dell, C.4
Furzer, A.5
Garman, S.6
Janus, D.7
Kane, P.D.8
Smith, G.9
Walker, C.V.10
Cockcroft, X.11
Ambler, J.12
Mitchelson, A.13
Talbot, M.D.14
Tweed, M.15
Wills, N.16
-
7
-
-
79952829832
-
-
U.S. Patent 20070293512, CAN 144:69842.
-
Yoshida, S.; Kobayashi, K.; Mochiduki, N.; Yamakawa, T.; Kobayashi, T.; Shinohara, Y. U.S. Patent 20070293512, 2007, CAN 144:69842.
-
(2007)
-
-
Yoshida, S.1
Kobayashi, K.2
Mochiduki, N.3
Yamakawa, T.4
Kobayashi, T.5
Shinohara, Y.6
-
8
-
-
79952847370
-
-
U.S. Patent 20070049596, CAN 146:273992.
-
Pei, Z.; von Geldern, T.; Madar, D. J.; Li, X.; Basha, F.; Yong, H.; Longenecker, K. L.; Backes, B. J.; Judd, A. S.; Mulhern, M. M.; Stewart, K. D. U.S. Patent 20070049596, 2007, CAN 146:273992.
-
(2007)
-
-
Pei, Z.1
Von Geldern, T.2
Madar, D.J.3
Li, X.4
Basha, F.5
Yong, H.6
Longenecker, K.L.7
Backes, B.J.8
Judd, A.S.9
Mulhern, M.M.10
Stewart, K.D.11
-
9
-
-
0036924776
-
-
Process Mass Intensity (PMI) is defined as the total mass of raw materials input divided by the mass of final Active Pharmaceutical Ingredient (API) output. It is adopted by the ACS Green Chemistry Institute as one of the benchmarks to measure the environmental impact and sustainability of chemical processes. For a review of PMI and other similar benchmarks, see: Constable, D. J. C.; Curzons, A. D.; Cunningham, V. L. Green Chem. 2002, 4, 521
-
(2002)
Green Chem.
, vol.4
, pp. 521
-
-
Constable, D.J.C.1
Curzons, A.D.2
Cunningham, V.L.3
-
10
-
-
0002306931
-
-
2O, 80 °C, 2 h, 100% yield. See Yousif, N. M. Tetrahedron 1989, 45, 4599
-
(1989)
Tetrahedron
, vol.45
, pp. 4599
-
-
Yousif, N.M.1
-
11
-
-
79952859571
-
-
For an example of using chloropyrimidine as desulfhydrating reagent, see Kondo, K.; Komamura, C.; Murakami, M.; Takemoto, K. Synth. Commun. 1985, 15, 171
-
(1985)
Synth. Commun.
, vol.15
, pp. 171
-
-
Kondo, K.1
Komamura, C.2
Murakami, M.3
Takemoto, K.4
-
12
-
-
84986516402
-
-
To the best of our knowledge, such couplings have only been reported with 2,3-dihalo-quinoxaline and quinones. See Katritzky, A. R.; Fan, W. Q. J. Heterocycl. Chem. 1988, 25, 901
-
(1988)
J. Heterocycl. Chem.
, vol.25
, pp. 901
-
-
Katritzky, A.R.1
Fan, W.Q.2
-
16
-
-
65349183594
-
-
Li, X.; Shocron, E.; Song, A.; Patel, N.; Sun, C. L. Bioorg. Med. Chem. Lett. 2009, 19, 2860
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 2860
-
-
Li, X.1
Shocron, E.2
Song, A.3
Patel, N.4
Sun, C.L.5
-
17
-
-
65949099699
-
-
Ragan, J. A.; Bourassa, D. E.; Blunt, J.; Breen, D.; Busch, F. R.; Cordi, E. M.; Damon, D. B.; Do, N.; Engtrakul, A.; Lynch, D.; McDermott, R. E.; Mongillo, J. A.; O'Sullivan, M. M.; Rose, P. R.; Vanderplas, B. C. Org. Process Res. Dev. 2009, 13, 186
-
(2009)
Org. Process Res. Dev.
, vol.13
, pp. 186
-
-
Ragan, J.A.1
Bourassa, D.E.2
Blunt, J.3
Breen, D.4
Busch, F.R.5
Cordi, E.M.6
Damon, D.B.7
Do, N.8
Engtrakul, A.9
Lynch, D.10
McDermott, R.E.11
Mongillo, J.A.12
O'Sullivan, M.M.13
Rose, P.R.14
Vanderplas, B.C.15
-
19
-
-
79952855891
-
-
EP 2036561, CAN 148:45810.
-
Hirano, M.; Yamakawa, T.; Ishikawa, T.; Saito, H. EP 2036561, 2009, CAN 148:45810.
-
(2009)
-
-
Hirano, M.1
Yamakawa, T.2
Ishikawa, T.3
Saito, H.4
-
21
-
-
17944369343
-
-
Ali, A.; Aster, S. D.; Graham, D. W.; Patel, G. F.; Taylor, G. E.; Tolman, R. L.; Painter, R. E.; Silver, L. L.; Young, K.; Ellsworth, K.; Geissler, W.; Harris, G. S. Bioorg. Med. Chem. Lett. 2001, 11, 2185
-
(2001)
Bioorg. Med. Chem. Lett.
, vol.11
, pp. 2185
-
-
Ali, A.1
Aster, S.D.2
Graham, D.W.3
Patel, G.F.4
Taylor, G.E.5
Tolman, R.L.6
Painter, R.E.7
Silver, L.L.8
Young, K.9
Ellsworth, K.10
Geissler, W.11
Harris, G.S.12
-
22
-
-
64249094188
-
-
Doláková, P.; Dračínský, M.; Masojídková, M.; Šolínová, V.; Kašička, V.; Holý, A. Eur. J. Med. Chem. 2009, 44, 2408
-
(2009)
Eur. J. Med. Chem.
, vol.44
, pp. 2408
-
-
Doláková, P.1
Dračínský, M.2
Masojídková, M.3
Šolínová, V.4
Kašička, V.5
Holý, A.6
-
25
-
-
33947489191
-
-
For such cyclizations in polyphosphoric acid (PPA), see ref 7 and Fu, S.-C. J.; Chinoporos, E.; Terzian, H. J. Org. Chem. 1965, 30, 1916
-
(1965)
J. Org. Chem.
, vol.30
, pp. 1916
-
-
Fu, S.-C.J.1
Chinoporos, E.2
Terzian, H.3
-
26
-
-
79952851861
-
-
See Supporting Information for more details.
-
See Supporting Information for more details.
-
-
-
-
27
-
-
79952852079
-
-
The isolated product was found to contain ∼0.5 equiv of HCl based on elemental analysis. See Experimental Section for details.
-
The isolated product was found to contain ∼0.5 equiv of HCl based on elemental analysis. See Experimental Section for details.
-
-
-
|